Find a supervisor

Potential supervisors and their fields of research are featured below.

Dr Monica Barratt:
Drugs and the internet; Drugs on the dark net; Impacts of drug laws and policies; Consumer involvement; Digital research methods.

Dr Emma Barrett:
Comorbid mental health and substance use disorders; forensic implications of comorbidity; PTSD, aggression; mental health treatment in forensic settings.

Dr Courtney Breen:
Randomised controlled trials, alcohol harms and substance use in pregnancy.

Associate Professor Lucy Burns:
Drugs and homelessness; drug use and gender; drug use and ageing; epidemiology of drug use and trends; alcohol and other drugs during pregnancy.

Dr Natacha Carragher:
Diagnosis and classification of common mental health and substance use disorders; comorbidity; epidemiological research; latent variable modelling.

Dr Jenny Chalmers:  
Implications of alcohol pricing policy for alcohol and illicit drug use; alcohol industry responses to government efforts to increase the price of alcohol; unmet demand for alcohol and drug treatment.

Dr Katrina Champion:
Multiple health behaviour change, prevention and early intervention of alcohol and other drug use, Internet-based interventions, randomised controlled trials.

Professor Jan Copeland:  
Cannabis, evaluation of information dissemination methodologies, psycho-social and pharmacotherapy intervention trials for cannabis use related problems and disorder, measurement and monitoring of treatment outcome, and women’s treatment.

Professor Shane Darke:
Physical and psychological harms of illicit drug use.

Professor Louisa Degenhardt:
Epidemiology of illicit drug use (especially cannabis, amphetamines, cocaine and heroin), mortality among illicit drug users, drug use among young people, crime among heroin dependent people, injecting drug use, pharmaceutical opioid use, including by people who are living with chronic pain.

Professor Kate Dolan:
HIV prevention and drug treatment in developing countries; hepatitis C research and prison research; drug use and treatment in women.

Dr Phuong Hoang:
Program and policy evaluation; Health economics; Cost-Benefit Analysis (CBA) of health interventions among illicit drug users in Australia.

Dr Caitlin Hughes:
Drugs and crime; impacts of drug laws, policing and criminal justice policies; drug law reform; police and court diversion; drug markets, supply and trafficking.

Dr Delyse Hutchinson:
Effects of drug use on children and families.

Dr Sharlene Kaye:
Psychostimulant use and associated harms. Attention Deficit Hyperactivity Disorder and substance use disorders.

Dr Sarah Larney:
Opioid dependence and related harms, including hepatitis C virus, injecting related injuries and diseases, and contact with the criminal justice system. Dr Larney is particularly seeking a PhD student to undertake work on a population-level linked dataset of opioid treatment episodes, hospital admissions and emergency department visits. 

Professor Richard Mattick:
Pharmacotherapies and other treatment for Drug and Alcohol Dependence. Effects of drug use on children and families.

Associate Professor Katherine Mills:
Co-occurrence of substance use and mental health disorders.

Dr Nicola Newton:
Prevention and early intervention of alcohol and other drug use. Internet-based programs and personality-targeted interventions.

Dr Suzanne Nielsen:
Treatment and prevention strategies for pharmaceutical drug dependence, over-the-counter codeine dependence, long-term outcomes for pharmaceutical opioid dependent people, acute and chronic pain management for opioid dependent people, benzodiazepine use amongst opioid dependent people. Methodological expertise includes clinical trials, including lab-based psychopharmacological studies, interview based data- collection and online surveys, prospective cohort studies.

Dr Katrina Prior:
Anxiety; comorbid anxiety and substance use disorders; prevention and early intervention of mental health and/or alcohol and other drug use; randomised controlled trials; internet-based programs for young people.

Professor Alison Ritter:
Drug policy – improving the evidence, studying policy making, developing models.

Professor Anthony Shakeshaft:
Intervention research, including prevention, early intervention, clinical services and policy agencies. Particular areas of interest are interventions in collaboration with Indigenous Australians and in rural/remote communities.

Dr Marian Shanahan: 
Health economics, economic evaluations of interventions and treatment for illicit drug and alcohol use, cost effectiveness analysis. 

Associate Professor Tim Slade:
Epidemiology of alcohol use and alcohol use disorders, particularly in adolescence and young adulthood; diagnosis and classification of mental and substance use disorders with a focus on DSM-5.

Dr Janette Smith:
Neurocognitive deficits in substance abuse.

Dr Lexine Stapinski:
Anxiety disorders, comorbid mental health and substance use disorders, treatment and early intervention, clinical psychology.  

Dr Emily Stockings:
Mental health services, policy, prevention and treatment provision, comorbid mental and physical conditions, smoking cessation, smoke-free policy, randomised controlled trials, intervention research. 

Dr Wendy Swift:
Epidemiology of cannabis use and related harms; co-occurrence of substance use and mental health disorders.

Professor Maree Teesson:
Mental disorders and drug and alcohol use; prevention; trials in adolescents; clinical trials of new treatments; adolescent brain development and drug use.